HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang Guo Selected Research

Inflammation (Inflammations)

2/2024In Situ Piezoelectric-Catalytic Anti-Inflammation Promotes the Rehabilitation of Acute Spinal Cord Injury in Synergy.
1/2024Glycyrrhizin attenuates myocardial ischemia reperfusion injury by suppressing Inflammation, oxidative stress, and ferroptosis via the HMGB1-TLR4-GPX4 pathway.
6/2023Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.
6/2022Calycosin prevents IL-1β-induced articular chondrocyte damage in osteoarthritis through regulating the PI3K/AKT/FoxO1 pathway.
10/2021HA of H1N1 enhanced the expression of ICAM-1 and IL-6 in HUVECs and pathological injury in the lungs in mice.
10/2021Role of the CTRP family in tumor development and progression.
1/2020Computational Prediction of Antiangiogenesis Synergistic Mechanisms of Total Saponins of Panax japonicus Against Rheumatoid Arthritis.
3/2016A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage.
11/2011An in vitro evaluation of inflammation response of titanium functionalized with heparin/fibronectin complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang Guo Research Topics

Disease

130Nasopharyngeal Carcinoma
01/2024 - 01/2002
66Neoplasms (Cancer)
01/2024 - 01/2002
49Neoplasm Metastasis (Metastasis)
06/2023 - 01/2002
9Inflammation (Inflammations)
02/2024 - 11/2011
9Ulcerative Colitis
11/2023 - 11/2021
8Necrosis
02/2024 - 06/2009
8Rheumatoid Arthritis
03/2020 - 06/2017
7Infections
07/2023 - 09/2014
5Hypoxia (Hypoxemia)
11/2023 - 04/2006
5COVID-19
10/2023 - 10/2021
5Carcinogenesis
01/2020 - 01/2006
4Hemorrhage
02/2024 - 11/2019
4Poisoning
10/2023 - 11/2015
4Rib Fractures (Rib Fracture)
07/2023 - 01/2019
4Mucositis
01/2022 - 01/2017
4Moyamoya Disease (Moya-Moya Disease)
11/2021 - 01/2016
3Osteoarthritis
05/2024 - 06/2022
3Pneumococcal Infections
01/2024 - 01/2021
3Melanoma (Melanoma, Malignant)
04/2023 - 02/2015
3Human Influenza (Influenza)
11/2022 - 03/2020
3Bone Fractures (Bone Fracture)
10/2022 - 04/2014
3Pneumonia (Pneumonitis)
04/2022 - 01/2021
3Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 08/2019
3Squamous Cell Carcinoma of Head and Neck
01/2021 - 12/2004
3Neutropenia
01/2021 - 09/2013
3Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2021 - 04/2004
3Body Weight (Weight, Body)
01/2020 - 07/2014
3Type 2 Diabetes Mellitus (MODY)
07/2014 - 11/2012
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2024 - 01/2022
2Pituitary Neoplasms (Pituitary Adenoma)
08/2023 - 03/2023
2Opportunistic Infections (Opportunistic Infection)
07/2023 - 04/2023
2Gastroenteritis
01/2023 - 10/2022
2Thrombocytopenia (Thrombopenia)
01/2023 - 01/2018
2Anemia
01/2022 - 01/2015

Drug/Important Bio-Agent (IBA)

29DNA (Deoxyribonucleic Acid)IBA
05/2023 - 12/2002
15Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2002
14Cisplatin (Platino)FDA LinkGeneric
01/2022 - 12/2004
13Biomarkers (Surrogate Marker)IBA
05/2024 - 07/2007
9tofacitinibIBA
11/2023 - 11/2021
7PlatinumIBA
04/2023 - 02/2010
7VaccinesIBA
11/2022 - 01/2021
7Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 02/2010
6Monoclonal AntibodiesIBA
01/2021 - 01/2014
6Indicators and Reagents (Reagents)IBA
01/2017 - 10/2004
5Capecitabine (Xeloda)FDA Link
01/2024 - 04/2004
5Janus Kinase InhibitorsIBA
11/2023 - 11/2021
5LipidsIBA
06/2023 - 07/2014
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2019 - 08/2015
5C-Reactive ProteinIBA
07/2018 - 01/2013
5Immunoglobulin A (IgA)IBA
11/2017 - 03/2003
4Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2024 - 03/2020
4EnzymesIBA
11/2023 - 07/2012
4Therapeutic UsesIBA
11/2023 - 03/2009
4Glucose (Dextrose)FDA LinkGeneric
10/2021 - 12/2013
4Hemoglobins (Hemoglobin)IBA
06/2020 - 06/2005
4Carboplatin (JM8)FDA LinkGeneric
01/2016 - 02/2010
4Endothelin A ReceptorIBA
08/2013 - 05/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2024 - 04/2022
3MicroRNAs (MicroRNA)IBA
05/2023 - 04/2020
3TitaniumIBA
12/2022 - 11/2011
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2022 - 08/2013
3ImmunosorbentsIBA
06/2022 - 07/2012
3CytokinesIBA
06/2022 - 08/2015
3Cytidine Triphosphate (CTP)IBA
11/2021 - 01/2016
3Complement System Proteins (Complement)IBA
01/2021 - 02/2014
33-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA
01/2021 - 01/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2019 - 08/2015
3Matrix Metalloproteinases (MMPs)IBA
01/2019 - 12/2013
3mavrilimumabIBA
01/2018 - 06/2017
3Messenger RNA (mRNA)IBA
01/2017 - 12/2002
3raf KinasesIBA
09/2016 - 03/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 11/2023
2Bone Cements (Bone Glue)IBA
01/2024 - 01/2023
2SolventsIBA
10/2023 - 01/2017
2Inactivated VaccinesIBA
10/2023 - 10/2022
2Metalloproteases (Metalloproteinases)IBA
08/2023 - 01/2019
2InterferonsIBA
07/2023 - 04/2014
2Long Noncoding RNAIBA
01/2023 - 01/2020
2GlucosidesIBA
01/2023 - 09/2018
2CollagenIBA
12/2022 - 10/2015
2Influenza Vaccines (Influenza Vaccine)FDA Link
11/2022 - 03/2020
2COVID-19 VaccinesIBA
10/2022 - 04/2022
2MXeneIBA
03/2022 - 01/2021

Therapy/Procedure

49Radiotherapy
05/2023 - 03/2003
36Chemoradiotherapy
06/2023 - 03/2008
27Drug Therapy (Chemotherapy)
04/2023 - 03/2008
21Induction Chemotherapy
04/2023 - 10/2009
20Therapeutics
05/2024 - 07/2008
19Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021 - 12/2012
5Neoadjuvant Therapy
01/2019 - 09/2013
5Re-Irradiation
10/2016 - 07/2007
4Aftercare (After-Treatment)
05/2023 - 03/2003
3Length of Stay
04/2024 - 01/2019
3Immunotherapy
03/2022 - 02/2015
3Conservative Treatment
07/2020 - 10/2013
2Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 08/2023
2Adjuvant Chemotherapy
10/2022 - 01/2019
2Phototherapy (Light Therapy)
03/2022 - 01/2021
2TP protocol
01/2022 - 01/2022